These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24228114)

  • 21. Retinoic acid receptor-related receptor alpha (RORalpha) is a prognostic marker for hepatocellular carcinoma.
    Fu RD; Qiu CH; Chen HA; Zhang ZG; Lu MQ
    Tumour Biol; 2014 Aug; 35(8):7603-10. PubMed ID: 24798975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and functional significance of the erythropoietin receptor in hepatocellular carcinoma.
    Shin M; Hong D; Zhang Z; Kim YM; Lee W; Joh JW; Kim SJ
    HPB (Oxford); 2013 Dec; 15(12):965-75. PubMed ID: 23496059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Connexin-43 can delay early recurrence and metastasis in patients with hepatitis B-related hepatocellular carcinoma and low serum alpha-fetoprotein after radical hepatectomy.
    Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY
    BMC Cancer; 2013 Jun; 13():306. PubMed ID: 23800357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of Leucine Zipper Protein mRNA in Hepatocellular Carcinoma Associated With Poor Prognosis.
    Li G; Yuan L; Liu D; Liu J
    Technol Cancer Res Treat; 2016 Jun; 15(3):517-22. PubMed ID: 26031464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of RPS6KB1 predicts worse prognosis in primary HCC patients.
    Li PD; Zhang WJ; Zhang MY; Yuan LJ; Cha YL; Ying XF; Wu G; Wang HY
    Med Oncol; 2012 Dec; 29(5):3070-6. PubMed ID: 22684641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The tumor suppressor NPRL2 in hepatocellular carcinoma plays an important role in progression and can be served as an independent prognostic factor.
    Otani S; Takeda S; Yamada S; Sakakima Y; Sugimoto H; Nomoto S; Kasuya H; Kanazumi N; Nagasaka T; Nakao A
    J Surg Oncol; 2009 Oct; 100(5):358-63. PubMed ID: 19274676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.
    Wang F; Qiang Y; Zhu L; Jiang Y; Wang Y; Shao X; Yin L; Chen J; Chen Z
    Tumour Biol; 2016 Aug; 37(8):10235-46. PubMed ID: 26831666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic significance of FOXQ1 oncogene overexpression in human hepatocellular carcinoma.
    Wang W; He S; Ji J; Huang J; Zhang S; Zhang Y
    Pathol Res Pract; 2013 Jun; 209(6):353-8. PubMed ID: 23623360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma.
    Chen XQ; He JR; Wang HY
    Med Oncol; 2012 Sep; 29(3):1843-9. PubMed ID: 21987076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CIP2A is highly expressed in hepatocellular carcinoma and predicts poor prognosis.
    He H; Wu G; Li W; Cao Y; Liu Y
    Diagn Mol Pathol; 2012 Sep; 21(3):143-9. PubMed ID: 22847158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased expression of liver-type fatty acid-binding protein is associated with poor prognosis in hepatocellular carcinoma.
    Wang B; Tao X; Huang CZ; Liu JF; Ye YB; Huang AM
    Hepatogastroenterology; 2014; 61(133):1321-6. PubMed ID: 25436304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated ZC3H15 increases HCC growth and predicts poor survival after surgical resection.
    Jiang BG; Wan ZH; Huang J; Li LM; Liu H; Fu SY; Yang Y; Zhang J; Yuan SX; Wang RY; Yang Y; Gu FM; Dong LW; Pan ZY; Zhou WP
    Oncotarget; 2016 Jun; 7(24):37238-37249. PubMed ID: 27191988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High expression of N-acetyltransferase 10: a novel independent prognostic marker of worse outcome in patients with hepatocellular carcinoma.
    Zhang X; Liu J; Yan S; Huang K; Bai Y; Zheng S
    Int J Clin Exp Pathol; 2015; 8(11):14765-71. PubMed ID: 26823802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of MAGE-D4 expression in hepatocellular carcinoma in Japanese patients.
    Takami H; Kanda M; Oya H; Hibino S; Sugimoto H; Suenaga M; Yamada S; Nishikawa Y; Asai M; Fujii T; Nomoto S; Kodera Y
    J Surg Oncol; 2013 Dec; 108(8):557-62. PubMed ID: 24068544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High expression of AP-4 predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy.
    Hu BS; Zhao G; Yu HF; Chen K; Dong JH; Tan JW
    Tumour Biol; 2013 Feb; 34(1):271-6. PubMed ID: 23055200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypermethylation of ACP1, BMP4, and TSPYL5 in Hepatocellular Carcinoma and Their Potential Clinical Significance.
    Qiu X; Hu B; Huang Y; Deng Y; Wang X; Zheng F
    Dig Dis Sci; 2016 Jan; 61(1):149-57. PubMed ID: 26386860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High NEK2 Expression Is a Predictor of Tumor Recurrence in Hepatocellular Carcinoma Patients After Hepatectomy.
    Wubetu GY; Morine Y; Teraoku H; Yoshikawa M; Ishikawa D; Yamada S; Ikemoto T; Saito YU; Imura S; Shimada M
    Anticancer Res; 2016 Feb; 36(2):757-62. PubMed ID: 26851035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased Expression of Lysine-Specific Demethylase 5B (KDM5B) Promotes Tumor Cell Growth in Hep3B Cells and is an Independent Prognostic Factor in Patients with Hepatocellular Carcinoma.
    Gong J; Yan S; Yu H; Zhang W; Zhang D
    Med Sci Monit; 2018 Oct; 24():7586-7594. PubMed ID: 30353907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High expression of proline-rich tyrosine kinase 2 is associated with poor survival of hepatocellular carcinoma via regulating phosphatidylinositol 3-kinase/AKT pathway.
    Cao J; Chen Y; Fu J; Qian YW; Ren YB; Su B; Luo T; Dai RY; Huang L; Yan JJ; Wu MC; Yan YQ; Wang HY
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S312-23. PubMed ID: 22618716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and significance of ETFDH in hepatocellular carcinoma.
    Wu Y; Zhang X; Shen R; Huang J; Lu X; Zheng G; Chen X
    Pathol Res Pract; 2019 Dec; 215(12):152702. PubMed ID: 31704152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.